Antibacterial agent 353
Antibacterial agent 353 is an antibacterial agent with bactericidal activity against multidrug-resistant pathogens including Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Methicillin (HY-121544)-resistant Staphylococcus aureus. Antibacterial agent 353 disrupts bacterial membrane integrity, leading to cell lysis and death. Antibacterial agent 353 demonstrates in vivo antibacterial activity in the Galleria mellonella larval infection model. Antibacterial agent 353 can be used for the research of multidrug-resistant bacterial infections.
For research use only. We do not sell to patients.
- Formula: C20H33NO4
- Molecular Weight:351.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
Antibacterial agent 353 (Compound 17j) (0.125-8 μg/mL) potently inhibits and kills Pseudomonas aeruginosa ATCC 15442 (MIC = 0.125 μg/mL, MBC = 1 μg/mL), Acinetobacter baumannii ATCC 19606 (MIC = 0.25 μg/mL, MBC = 1 μg/mL), Klebsiella pneumoniae ATCC 13883 (MIC = 0.25 μg/mL, MBC = 1 μg/mL), and methicillin-resistant Staphylococcus aureus ATCC 43300 (MIC = 1 μg/mL, MBC = 8 μg/mL)[1].
Antibacterial agent 353 (0.25-4 μg/mL; 0-24 h) exhibits concentration- and time-dependent bactericidal activity against Pseudomonas aeruginosa ATCC 15442 and Acinetobacter baumannii ATCC 19606[1].
Antibacterial agent 353 (0.5-1 μg/mL) disrupts the membrane integrity of Pseudomonas aeruginosa ATCC 15442 in a concentration-dependent manner, causing cell rupture and death[1].
Antibacterial agent 353 (0-40 μM) exhibits very low in vitro cytotoxicity toward SMMC-7721, MCF7, and Beas-2B mammalian cell lines, with an IC50 >40 μM and a Selectivity Index >112.7[1].
Antibacterial agent 353 (0.125-8 μg/mL) shows no significant hemolytic toxicity toward rat red blood cells at concentrations up to 8 μg/mL, with hemolytic rates < 5% and a hemolytic Selectivity Index > 64[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:larvae[1]
-
Dosage:0.25 mg/kg; 0.5 mg/kg; 1 mg/kg
-
Administration:single dose; post-infection
-
Result:Achieved 60% larvae survival rate at 24 hours and 30% at 48 and 72 hours at 0.5 mg/kg.
Maintained 70% larvae survival rate at 24, 48, and 72 hours at 1 mg/kg.
Chemical Information
-
Molecular Weight 351.48
-
Formula C20H33NO4
-
SMILES
CCCCCCCCCCCCCNC(/C=C/C1=CC(OC1=O)O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Protein Extraction
Protein extraction uses physical, chemical or biological methods, such as ultrasonic disruption, salting out, cell lysis, electrophoresis, etc., to destroy the cell membrane structure and to separate the proteins from different components according to their characteristics.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Antibacterial agent 353
- Antibacterial agent353
- Antibacterial agent-353
- Bacterial
- Galleria mellonella
- Klebsiella pneumoniae
- Beas-2B
- bacterial membrane integrity
- methicillin-resistant Staphylococcus aureus
- SMMC-7721
- MCF7
- Pseudomonas aeruginosa
- Acinetobacter baumannii
- multidrug-resistant bacterial infections
- Inhibitor
- inhibitor
- inhibit